Do not stop or change your medication without speaking to a pharmacist or healthcare professional.
Recalls

Drug Recalls in Canada

Medication recalls and safety alerts, pulled directly from Health Canada's Recalls and Safety Alerts database — the same source your pharmacy checks.

Last synced Sep 28, 2026, 10:00 a.m.

1047 results

Apo-Semaglutide Injection

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-09-24

Moderate health risk

Novo-Gesic Forte 500 mg tablets (acetaminophen)

Generic acetaminophen by Teva recalled because it may contain foreign material

Type I2026-09-10

Highest health risk

JAMP Temozolomide

JAMP Temozolomide: Out-of-Specification (Assay)

Type II2026-08-31

Moderate health risk

Apo-Semaglutide

Apo-Semaglutide Injection : Incorrect dose display

Type II2026-08-27

Moderate health risk

Semaglutide Injection

Semaglutide Injection : Out-of-Specification (Impurity)

Type II2026-08-26

Moderate health risk

Twins Herbal Idakole and Twins Herbal Pelorie

Twins Herbal Products: Undeclared prescription drug (sildenafil)

Type I2026-08-25

Highest health risk

BONKY Injection, 1 mcg/mL Calcitriol

Importation of South Korean-Authorized BONKY Injection, 1 mcg/mL Calcitriol, due to the Current Shortage of Canadian-Authorized Calcitriol Injection USP, 1 mcg/mL

2026-08-24

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.

Type III2026-08-19

Low health risk

Various unauthorized health products, including prescription drugs

Unauthorized drugs seized from Rabais 4Saisons Inc. in Montreal, QC, may pose serious health risks

2026-08-18

Lactated Ringer's Injection USP

Lactated Ringer's Injection USP: Presence of Particulate Matter

Type I2026-08-17

Highest health risk

Teva-Pregabalin 150 mg capsules

Two lots of Teva-Pregabalin 150 mg capsules recalled due to cross-contamination with the drug sertraline

Type I2026-08-15

Highest health risk

Various unauthorized—including counterfeit—injectable health products

Unauthorized injectable health products sold online and seized from Dyosa Beauty & Wellness Lounge in Hamilton, ON, may pose serious health risks

2026-08-13

pms-IRBESARTAN 150 mg Tablet

pms-IRBESARTAN: Affected lot may contain pms-IRBESARTAN/HCTZ 150/12.5 mg tablets.

Type II2026-08-12

Moderate health risk

Semaglutide Injection

Semaglutide Injection: Incorrect Pen in Package

Type II2026-08-11

Moderate health risk

TEVA-ECTOSONE 0.1% Cream

TEVA-ECTOSONE 0.1% Cream; Affected lot may be missing lot number and expiry date

Type II2026-08-07

Moderate health risk

JAMP Methotrexate 10 mg Tablets

JAMP Methotrexate 10 mg Tablets: Affected lots may contain oversized tablets.

Type II2026-08-05

Moderate health risk

Femyso Mifepristone 200mg / Misoprostol 200 mcg tablet

Femyso: Affected lot may contain two green Mifepristone cartons or two pink Misoprostol cartons instead of one of each.

Type II2026-07-30

Moderate health risk

OXYGEN 100%

Oxygen 100%: Gas cylinders containing commercial grade oxygen

Type III2026-07-28

Low health risk

ATTITUDE Bathroom Cleaner Disinfectant

ATTITUDE Bathroom Cleaner Disinfectant: Affected lot may be missing expiry date

Type III2026-07-20

Low health risk

Supernova and Supreme Nicotine Film and Pouches

Supernova and Supreme Nicotine Film and Pouches Recall; No market authorization

Type II2026-07-15

Moderate health risk

Apo-Tiotropium 18 mcg Capsules

Apo-Tiotropium Capsules; Out-of-specification (particle size)

Type II2026-07-13

Moderate health risk

BD ChloraPrep™ Clear - 1mL Applicator

BD ChloraPrep™ Clear - 1mL Applicator: Product sterility

Type II2026-07-13

Moderate health risk

TAVNEOS (avacopan) capsules, 10 mg

TAVNEOS (avacopan) and Health Canada’s Review of Data Integrity Concerns

2026-07-07

JAMP Chlorthalidone 12.5 mg Tablets

JAMP Chlorthalidone 12.5 mg tablet: Out of specification (Dissolution)

Type III2026-07-06

Low health risk

Remifentanil hydrochloride for injection 1 mg/vial

Remifentanil hydrochloride for injection; Out of specification (Assay & Impurity)

Type II2026-06-26

Moderate health risk

Spiriva 18mcg capsule

Spiriva Capsules ; Out-of-specification (uniformity of delivered dose)

Type III2026-06-25

Low health risk

Ifosfamide for Injection, 1 g per vial

Importation of Chinese-Authorized Ifosfamide for Injection due to the Current Shortage of Canadian-Authorized IFEX (Ifosfamide for Injection)

2026-06-22

Lancora 5 mg tablet

Lancora Tablets; Broken / partial tablets in blister pack

Type III2026-06-16

Low health risk

Nicotine Pouch

Nicotine Pouch Recall; No market authorization

Type II2026-06-10

Moderate health risk

Sodium chloride injection; Sodium chloride Irrigation; (20 mmol/L) Potassium chloride in 5% Dextrose and 0.9% Sodium chloride injection; Lactated Ringer's injection

Baxter Corporation products recall; Blue cap breakage

Type III2026-06-08

Low health risk

Recall data is sourced from Health Canada's Recalls and Safety Alerts open dataset. MedShort.ca is an independent tracking tool and does not provide medical advice. See our guides for what to do if your medication is recalled.